Heart failure and iron deficiency
Conditions
Interventions
None listed
Sponsors
Van Buchem Stichting
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: This study encloses additional analyses on already frozen and stored blood samples of patients from an earlier judged study (NL16287.042.07). No inclusion criteria will be necessary for this study. For inclusion criteria, see protocol from study NL16287.042.07
Exclusion criteria
Exclusion criteria: This study encloses additional analyses on already frozen and stored blood samples of patients from an earlier judged study (NL16287.042.07). No exclusion criteria will be necessary for this study. For exclusion criteria, see protocol from study NL16287.042.07
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary study parametes/endpoint: Prognosis of ID, VB12D and FD in patients with chronic HF. Data on all cause mortality, HF hospitalization or the combined endpoint of both will be collected from the BENEFICIAL database. We will only collect data that were obtained during participation in the BENEFICIAL trial. Follow-up information after this trial will not be taken into consideration. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters/endpoints: Data will be collected from the BENEFICIAL database to investigate possible relationships between chronic HF patients with/without ID, VB12D or FD, or markers of these deficiencies, on: - Exercise capacity (peak oxygen consumption) - Blood markers (e.g. hemoglobin, markers of inflammation, NT-proBNP, renal function) - Echocardiographic parameters (systolic/diastolic function) - Non-invasive cardiac index (Nexfin) | — |
Countries
Netherlands
Outcome results
None listed